GREGORY WEAVER - 20 Jun 2023 Form 4 Insider Report for ATOSSA THERAPEUTICS, INC. (ATOS)

Role: EVP & CFO, Director
Signature: /s/ Gregory L. Weaver
Issuer symbol: ATOS
Transactions as of: 20 Jun 2023
Transactions value $: $48,500
Form type: 4
Filing time: 20 Jun 2023, 20:15:24 UTC
Previous filing: 05 Jun 2023
Next filing: 17 Nov 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ATOS	Common Stock	Purchase	$48,500	+50,000	+90,909%	$0.97	50,055	20 Jun 2023	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported represents the weighted average purchase price per share. The shares were purchased in multiple transactions at prices ranging from $0.93 to $0.99. Upon request from the staff of the U.S. Securities and Exchange Commission, the Issuer or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price.
F2	Includes shares of common stock purchased on November 21, 2013, which were previously reported on a Form 4 filed by the Reporting Person on November 22, 2013 but erroneously omitted in subsequent filings.

Content

The price reported represents the weighted average purchase price per share. The shares were purchased in multiple transactions at prices ranging from $0.93 to $0.99. Upon request from the staff of the U.S. Securities and Exchange Commission, the Issuer or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price.

Includes shares of common stock purchased on November 21, 2013, which were previously reported on a Form 4 filed by the Reporting Person on November 22, 2013 but erroneously omitted in subsequent filings.